Insider Transactions in Q1 2023 at Athenex, Inc. (ATNX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,525
+8.4%
|
$3,525
$1.39 P/Share
|
|
Mar 24
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
360
+10.78%
|
$360
$1.39 P/Share
|
|
Mar 24
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
8,201
+3.53%
|
$8,201
$1.39 P/Share
|
|
Mar 10
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
258
+8.97%
|
$258
$1.94 P/Share
|
|
Mar 10
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,526
+6.75%
|
$2,526
$1.94 P/Share
|
|
Mar 10
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
5,519
+2.49%
|
$5,519
$1.94 P/Share
|
|
Feb 24
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
1,591
+0.75%
|
$3,182
$2.74 P/Share
|
|
Feb 24
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,788
+5.23%
|
$3,576
$2.74 P/Share
|
|
Feb 24
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
182
+7.16%
|
$364
$2.74 P/Share
|
|
Feb 22
2023
|
Joe Annoni Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-40.0%
|
$500
$2.66 P/Share
|
|
Feb 22
2023
|
Joe Annoni Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
625
+50.0%
|
-
|
|
Feb 10
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,778
+3.44%
|
$0
$0.22 P/Share
|
|
Feb 10
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+4.85%
|
$0
$0.22 P/Share
|
|
Feb 10
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
19,378
+0.46%
|
$0
$0.22 P/Share
|
|
Jan 27
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,584
+5.88%
|
$0
$0.19 P/Share
|
|
Jan 27
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,323
+4.11%
|
$0
$0.19 P/Share
|
|
Jan 27
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
22,533
+0.54%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Manson Fok Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,323
+1.89%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
John Vierling Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,701
+28.21%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,130
+26.03%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Jinn Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,701
+7.47%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Stephanie A Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,538
+22.6%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Benson Kwan Hung Tsang Director |
BUY
Grant, award, or other acquisition
|
Direct |
61,831
+27.61%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,688
+6.48%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,344
+4.46%
|
$0
$0.19 P/Share
|
|
Jan 13
2023
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
23,441
+0.56%
|
$0
$0.19 P/Share
|